Pneumocystis Pneumonia in a Patient with Ovarian Cancer Receiving Olaparib Therapy-Reference-Cited by-同舟云学术

Pneumocystis Pneumonia in a Patient with Ovarian Cancer Receiving Olaparib Therapy

Published:2022-01-15 Issue:2 Volume:61 Page:217-221
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Himeji Daisuke¹,Tanaka Gen-ichi¹,Shiiba Ritsuya¹,Matsumoto Ryoichi¹,Takamura Kazuhiro²,Morishita Hirotaka²,Taniguchi Shuichi²,Moriguchi Sayaka³,Marutsuka Kousuke³

Affiliation:

1. Department of Internal Medicine, Miyazaki Prefectural Miyazaki Hospital, Japan

2. Department of Obstetrics and Gynecology, Miyazaki Prefectural Miyazaki Hospital, Japan

3. Department of Anatomic Pathology, Miyazaki Prefectural Miyazaki Hospital, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/61/2/61_7485-21/_pdf

Reference21 articles.

1. 1. Fillatre P, Decaux O, Jouneau S, et al. Incidence of Pneumocystis jiroveci pneumonia among groups at risk in HIV-negative patients. Am J Med 127: 1242.e11-1242.e17, 2014.

2. 2. Banerjee S, Gonzalez-Martin A, Harter P, et al. First-line PARP inhibitors in ovarian cancer: summary of an ESMO Open - Cancer Horizons round-table discussion. ESMO Open 5: 1-10, 2020.

3. 3. Salzer HJF, Schäfer G, Hoenigl M, et al. Clinical, diagnostic, and treatment disparities between HIV-infected and non-HIV-infected immunocompromised patients with Pneumocystis jirovecii pneumonia. Respiration 96: 52-65, 2018.

4. 4. Azoulay É, Bergeron A, Chevret S, Bele N, Schlemmer B, Menotti J. Polymerase chain reaction for diagnosing pneumocystis pneumonia in non-HIV immunocompromised patients with pulmonary infiltrates. Chest 135: 655-661, 2009.

5. 5. Tasaka S. Recent advances in the diagnosis and management of Pneumocystis pneumonia. Tuberc Respir Dis (Seoul) 83: 132-140, 2020.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence, caractéristiques et survie des patients présentant une pneumocystose en oncologie solide;Bulletin du Cancer;2024-09

2. Detection of pulmonary actinomycosis by metagenomic next-generation sequencing in a cancer patient receiving maintenance olaparib: A review and case report;Respiratory Medicine Case Reports;2024

3. Impact of Age on Poly(ADP-Ribose) Polymerase Inhibitor (PARPi)-Induced Lymphopenia: A Scoping Review of the Literature and Internal Analysis of a Retrospective Database;Drugs & Aging;2023-04-20

4. Drug-Induced Interstitial Lung Disease From PARP Inhibitors (Olaparib and Niraparib) for Ovarian Cancer;Annals of Internal Medicine: Clinical Cases;2023-03-01

5. Pneumocystis jirovecii Pneumonia in Three Patients With Breast Cancer Receiving Neoadjuvant Dose-Dense Chemotherapy;Cureus;2022-02-01